Mr. Jay Crowley, Vice President and UDI Practice Lead with USDM Life Sciences, shared the U.S. Food and Drug Administration Unique Device Identification (UDI) regulation implementation, progress and issues to date. He explained some important terms in the rule and shared typical issues that occur due to master data in the Global UDI Database (GUDID) and lack of barcode verification. He also shared his understanding of the conforming amendments and deadlines in the upcoming two years.
Review Mr. Crowley’s presentation.